Published in
Lippincott, Williams & Wilkins, AIDS, 18(31), p. 2503-2514, 2017
DOI: 10.1097/qad.0000000000001675
Links
Tools
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk:
Journal article published in 2017 by
José M. Gatell,
Lambert Assoumou,
Graeme Moyle,
Laura Waters,
Margaret Johnson,
Pere Domingo,
Julie Fox,
Esteban Martinez,
Hans–Jürgen Stellbrink,
Giovanni Guaraldi,
Mar Masia,
Mark Gompels,
Stephane De Wit,
Eric Florence 
,
Stefan Esser
and other authors.
,
Stefan Esser
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 